315 related articles for article (PubMed ID: 32098365)
1. The Timing and Extent of Motor Neuron Vulnerability in ALS Correlates with Accumulation of Misfolded SOD1 Protein in the Cortex and in the Spinal Cord.
Genc B; Gozutok O; Kocak N; Ozdinler PH
Cells; 2020 Feb; 9(2):. PubMed ID: 32098365
[TBL] [Abstract][Full Text] [Related]
2. Visualization of Sensory Neurons and Their Projections in an Upper Motor Neuron Reporter Line.
Genç B; Lagrimas AK; Kuru P; Hess R; Tu MW; Menichella DM; Miller RJ; Paller AS; Özdinler PH
PLoS One; 2015; 10(7):e0132815. PubMed ID: 26222784
[TBL] [Abstract][Full Text] [Related]
3. eGFP expression under UCHL1 promoter genetically labels corticospinal motor neurons and a subpopulation of degeneration-resistant spinal motor neurons in an ALS mouse model.
Yasvoina MV; Genç B; Jara JH; Sheets PL; Quinlan KA; Milosevic A; Shepherd GM; Heckman CJ; Özdinler PH
J Neurosci; 2013 May; 33(18):7890-904. PubMed ID: 23637180
[TBL] [Abstract][Full Text] [Related]
4. Early upregulation of cytosolic phospholipase A
Malada Edelstein YF; Solomonov Y; Hadad N; Alfahel L; Israelson A; Levy R
J Neuroinflammation; 2021 Nov; 18(1):274. PubMed ID: 34823547
[TBL] [Abstract][Full Text] [Related]
5. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
6. Misfolded SOD1 Accumulation and Mitochondrial Association Contribute to the Selective Vulnerability of Motor Neurons in Familial ALS: Correlation to Human Disease.
Abu-Hamad S; Kahn J; Leyton-Jaimes MF; Rosenblatt J; Israelson A
ACS Chem Neurosci; 2017 Oct; 8(10):2225-2234. PubMed ID: 28715630
[TBL] [Abstract][Full Text] [Related]
7. SQSTM1, a protective factor of SOD1-linked motor neuron disease, regulates the accumulation and distribution of ubiquitinated protein aggregates in neuron.
Mitsui S; Otomo A; Sato K; Ishiyama M; Shimakura K; Okada-Yamaguchi C; Warabi E; Yanagawa T; Aoki M; Shang HF; Hadano S
Neurochem Int; 2022 Sep; 158():105364. PubMed ID: 35640762
[TBL] [Abstract][Full Text] [Related]
8. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.
Leyton-Jaimes MF; Benaim C; Abu-Hamad S; Kahn J; Guetta A; Bucala R; Israelson A
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10198-203. PubMed ID: 27551074
[TBL] [Abstract][Full Text] [Related]
9. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord.
Yoshikawa M; Ishikawa C; Li H; Kudo T; Shiba D; Shirakawa M; Muratani M; Takahashi S; Aizawa S; Shiga T
Mol Cell Neurosci; 2022 Jul; 121():103745. PubMed ID: 35660087
[TBL] [Abstract][Full Text] [Related]
10. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
[TBL] [Abstract][Full Text] [Related]
11. Spinal inhibitory neurons degenerate before motor neurons and excitatory neurons in a mouse model of ALS.
Montañana-Rosell R; Selvan R; Hernández-Varas P; Kaminski JM; Sidhu SK; Ahlmark DB; Kiehn O; Allodi I
Sci Adv; 2024 May; 10(22):eadk3229. PubMed ID: 38820149
[TBL] [Abstract][Full Text] [Related]
12. Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G⁹³A transgenic ALS mice.
Ozdinler PH; Benn S; Yamamoto TH; Güzel M; Brown RH; Macklis JD
J Neurosci; 2011 Mar; 31(11):4166-77. PubMed ID: 21411657
[TBL] [Abstract][Full Text] [Related]
13. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
[TBL] [Abstract][Full Text] [Related]
14. Deletion of
Dermentzaki G; Politi KA; Lu L; Mishra V; Pérez-Torres EJ; Sosunov AA; McKhann GM; Lotti F; Shneider NA; Przedborski S
eNeuro; 2019; 6(1):. PubMed ID: 30815534
[TBL] [Abstract][Full Text] [Related]
15. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
16. Misfolded SOD1 is not a primary component of sporadic ALS.
Da Cruz S; Bui A; Saberi S; Lee SK; Stauffer J; McAlonis-Downes M; Schulte D; Pizzo DP; Parone PA; Cleveland DW; Ravits J
Acta Neuropathol; 2017 Jul; 134(1):97-111. PubMed ID: 28247063
[TBL] [Abstract][Full Text] [Related]
17. Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neurons.
Genç B; Jara JH; Sanchez SS; Lagrimas AKB; Gözütok Ö; Koçak N; Zhu Y; Hande Özdinler P
Gene Ther; 2022 Apr; 29(3-4):178-192. PubMed ID: 34853443
[TBL] [Abstract][Full Text] [Related]
18. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
Chi L; Ke Y; Luo C; Gozal D; Liu R
Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis.
Ringer C; Weihe E; Schütz B
Neurobiol Dis; 2012 Jan; 45(1):547-54. PubMed ID: 21964254
[TBL] [Abstract][Full Text] [Related]
20. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
